Porton Pharmasolutions Denmark ApS: Financial statements 2024
CVR: 43082671
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Porton Pharmasolutions Denmark ApS (CVR 43082671) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 3,796,289 and a net result of DKK -1,682,051 compared with DKK -3,327,784 the year before. Equity in the 2024 report amounted to DKK -4,078,165. The company had 1 employee in the financial year.
- Gross Profit
- DKK 3,796,289
- Profit/Loss
- DKK -1,682,051
- Equity
- DKK -4,078,165
- Total Assets
- DKK 3,457,911
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 3.8M | -1.7M | -4.1M | 1 |
| 2023 | - | -282K | -3.3M | -2.4M | 1 |
| 2022 | - | -959K | -3.1M | 932K | 1 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Porton Pharmasolutions Denmark ApS has published its annual report for 2023. Gross profit came to DKK -282,057, and the net result was DKK -3,327,784.
About Porton Pharmasolutions Denmark ApS
Porton Pharmasolutions Denmark ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2022. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Pavlos Kouroupis. The company is owned by Porton Pharmaceutical Chemicals GmbH. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 2,705,608 and a net result of DKK 94,702 compared with DKK -1,682,051 the year before. Equity in the 2025 report amounted to DKK -3,983,464.